« Back
Home /
Cetuximab (anti-EGFR)

Cetuximab (anti-EGFR)

Manufacturer	Selleckchem
Category	Oncology Neuroscience Neural Signaling Antibodies Primary Antibodies By Organ Bladder Cancer
Type	Antibody
Specific against	other
Amount	1 mg x 5
Item no.	A2000-5
CASRN	205923-56-4
eClass 6.1	32160702
eClass 9.0	32160702
Available
Description	Cetuximab, a novel molecular-targeted agent, is an inhibitor of EGFR monoclonal humanized antibody interacting with the extracellular binding site of EGFR to block ligand stimulation. MW : 145.781 KD.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg x 5

available

Delivery expected until 5/16/2024